Geode Capital Management, LLC Adicet Bio, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 768,566 shares of ACET stock, worth $730,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares

768,566

Previous 670,999 14.54%

Holding current value

$730,137

Previous $811,000 36.37%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.07 - $1.63 $104,396 - $159,034	97,567 Added 14.54%	768,566 $1.11 Million
Q2 2024 Aug 09, 2024	SELL	$1.21 - $2.4 $646,094 - $1.28 Million	-533,962 Reduced 44.31%	670,999 $811,000
Q1 2024 May 13, 2024	BUY	$1.76 - $3.45 $955,972 - $1.87 Million	543,166 Added 82.07%	1,204,961 $2.83 Million
Q4 2023 Feb 13, 2024	BUY	$1.11 - $1.89 $32,013 - $54,509	28,841 Added 4.56%	661,795 $1.25 Million
Q3 2023 Nov 13, 2023	SELL	$1.37 - $3.4 $20 - $51	-15 Reduced -0.0%	632,954 $867,000
Q2 2023 Aug 11, 2023	BUY	$2.13 - $7.13 $57,041 - $190,941	26,780 Added 4.42%	632,969 $1.54 Million
Q1 2023 May 15, 2023	BUY	$5.52 - $9.23 $88,502 - $147,984	16,033 Added 2.72%	606,189 $3.49 Million
Q4 2022 Feb 13, 2023	BUY	$7.72 - $21.27 $398,822 - $1.1 Million	51,661 Added 9.59%	590,156 $5.28 Million
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $1.57 Million - $2.19 Million	116,927 Added 27.74%	538,495 $7.66 Million
Q2 2022 Aug 12, 2022	BUY	$10.26 - $20.81 $305,060 - $618,743	29,733 Added 7.59%	421,568 $6.15 Million
Q1 2022 May 13, 2022	BUY	$11.53 - $19.97 $960,610 - $1.66 Million	83,314 Added 27.0%	391,835 $7.82 Million
Q4 2021 Feb 11, 2022	SELL	$7.37 - $17.49 $227,283 - $539,374	-30,839 Reduced 9.09%	308,521 $5.4 Million
Q3 2021 Nov 12, 2021	BUY	$6.29 - $9.93 $132,209 - $208,718	21,019 Added 6.6%	339,360 $2.66 Million
Q2 2021 Aug 13, 2021	BUY	$9.19 - $15.93 $1.83 Million - $3.17 Million	199,026 Added 166.81%	318,341 $3.28 Million
Q1 2021 May 12, 2021	BUY	$12.12 - $17.17 $1.04 Million - $1.47 Million	85,839 Added 256.42%	119,315 $1.56 Million
Q4 2020 Feb 12, 2021	BUY	$10.36 - $14.77 $48,225 - $68,754	4,655 Added 16.15%	33,476 $470,000
Q3 2020 Nov 13, 2020	BUY	$10.18 - $21.4 $293,397 - $616,769	28,821 New	28,821 $342,000

Others Institutions Holding ACET

# of Institutions

Shares Held

59.2M

Call Options Held

4.2K

Put Options Held

6.7K

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $38M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Adicet Bio, Inc. Transaction History